1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Specialty Pharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Specialty Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibody
1.4.3 Hormone
1.4.4 Growth Factors
1.4.5 Other
1.5 Market by Application
1.5.1 Global Specialty Pharmaceutical Market Share by Application: 2021-2026
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Specialty Pharmaceutical Market
1.8.1 Global Specialty Pharmaceutical Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Specialty Pharmaceutical Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Specialty Pharmaceutical Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Specialty Pharmaceutical Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Specialty Pharmaceutical Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Specialty Pharmaceutical Sales Volume Market Share by Region (2015-2020)
3.2 Global Specialty Pharmaceutical Sales Revenue Market Share by Region (2015-2020)
3.3 North America Specialty Pharmaceutical Sales Volume
3.3.1 North America Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.3.2 North America Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Specialty Pharmaceutical Sales Volume
3.4.1 East Asia Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Specialty Pharmaceutical Sales Volume (2015-2020)
3.5.1 Europe Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Specialty Pharmaceutical Sales Volume (2015-2020)
3.6.1 South Asia Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Specialty Pharmaceutical Sales Volume (2015-2020)
3.7.1 Southeast Asia Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Specialty Pharmaceutical Sales Volume (2015-2020)
3.8.1 Middle East Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Specialty Pharmaceutical Sales Volume (2015-2020)
3.9.1 Africa Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Specialty Pharmaceutical Sales Volume (2015-2020)
3.10.1 Oceania Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Specialty Pharmaceutical Sales Volume (2015-2020)
3.11.1 South America Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.11.2 South America Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Specialty Pharmaceutical Sales Volume (2015-2020)
3.12.1 Rest of the World Specialty Pharmaceutical Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Specialty Pharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Specialty Pharmaceutical Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Specialty Pharmaceutical Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Specialty Pharmaceutical Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Specialty Pharmaceutical Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Specialty Pharmaceutical Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Specialty Pharmaceutical Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Specialty Pharmaceutical Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Specialty Pharmaceutical Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Specialty Pharmaceutical Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Specialty Pharmaceutical Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Specialty Pharmaceutical Sales Volume Market Share by Type (2015-2020)
14.2 Global Specialty Pharmaceutical Sales Revenue Market Share by Type (2015-2020)
14.3 Global Specialty Pharmaceutical Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Specialty Pharmaceutical Consumption Volume by Application (2015-2020)
15.2 Global Specialty Pharmaceutical Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Specialty Pharmaceutical Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer Specialty Pharmaceutical Product Specification
16.1.3 Pfizer Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Merck
16.2.1 Merck Company Profile
16.2.2 Merck Specialty Pharmaceutical Product Specification
16.2.3 Merck Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 AbbVie
16.3.1 AbbVie Company Profile
16.3.2 AbbVie Specialty Pharmaceutical Product Specification
16.3.3 AbbVie Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Roche
16.4.1 Roche Company Profile
16.4.2 Roche Specialty Pharmaceutical Product Specification
16.4.3 Roche Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Sanofi-Aventis
16.5.1 Sanofi-Aventis Company Profile
16.5.2 Sanofi-Aventis Specialty Pharmaceutical Product Specification
16.5.3 Sanofi-Aventis Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Amgen
16.6.1 Amgen Company Profile
16.6.2 Amgen Specialty Pharmaceutical Product Specification
16.6.3 Amgen Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Novartis
16.7.1 Novartis Company Profile
16.7.2 Novartis Specialty Pharmaceutical Product Specification
16.7.3 Novartis Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Johnson & Johnson
16.8.1 Johnson & Johnson Company Profile
16.8.2 Johnson & Johnson Specialty Pharmaceutical Product Specification
16.8.3 Johnson & Johnson Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Novo Nordisk
16.9.1 Novo Nordisk Company Profile
16.9.2 Novo Nordisk Specialty Pharmaceutical Product Specification
16.9.3 Novo Nordisk Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Eli Lilly
16.10.1 Eli Lilly Company Profile
16.10.2 Eli Lilly Specialty Pharmaceutical Product Specification
16.10.3 Eli Lilly Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Gelgen Biopharma
16.11.1 Gelgen Biopharma Company Profile
16.11.2 Gelgen Biopharma Specialty Pharmaceutical Product Specification
16.11.3 Gelgen Biopharma Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 3sbio
16.12.1 3sbio Company Profile
16.12.2 3sbio Specialty Pharmaceutical Product Specification
16.12.3 3sbio Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Innovent
16.13.1 Innovent Company Profile
16.13.2 Innovent Specialty Pharmaceutical Product Specification
16.13.3 Innovent Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Biotech Pharma
16.14.1 Biotech Pharma Company Profile
16.14.2 Biotech Pharma Specialty Pharmaceutical Product Specification
16.14.3 Biotech Pharma Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Changchun High Tech
16.15.1 Changchun High Tech Company Profile
16.15.2 Changchun High Tech Specialty Pharmaceutical Product Specification
16.15.3 Changchun High Tech Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 CP Guojian Pharmacy
16.16.1 CP Guojian Pharmacy Company Profile
16.16.2 CP Guojian Pharmacy Specialty Pharmaceutical Product Specification
16.16.3 CP Guojian Pharmacy Specialty Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Specialty Pharmaceutical Manufacturing Cost Analysis
17.1 Specialty Pharmaceutical Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Specialty Pharmaceutical
17.4 Specialty Pharmaceutical Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Specialty Pharmaceutical Distributors List
18.3 Specialty Pharmaceutical Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Specialty Pharmaceutical (2021-2026)
20.2 Global Forecasted Revenue of Specialty Pharmaceutical (2021-2026)
20.3 Global Forecasted Price of Specialty Pharmaceutical (2015-2026)
20.4 Global Forecasted Production of Specialty Pharmaceutical by Region (2021-2026)
20.4.1 North America Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.3 Europe Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.7 Africa Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.9 South America Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Specialty Pharmaceutical Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Specialty Pharmaceutical by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Specialty Pharmaceutical by Country
21.2 East Asia Market Forecasted Consumption of Specialty Pharmaceutical by Country
21.3 Europe Market Forecasted Consumption of Specialty Pharmaceutical by Countriy
21.4 South Asia Forecasted Consumption of Specialty Pharmaceutical by Country
21.5 Southeast Asia Forecasted Consumption of Specialty Pharmaceutical by Country
21.6 Middle East Forecasted Consumption of Specialty Pharmaceutical by Country
21.7 Africa Forecasted Consumption of Specialty Pharmaceutical by Country
21.8 Oceania Forecasted Consumption of Specialty Pharmaceutical by Country
21.9 South America Forecasted Consumption of Specialty Pharmaceutical by Country
21.10 Rest of the world Forecasted Consumption of Specialty Pharmaceutical by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer